Results 151 to 160 of about 58,007 (253)

Safety of Anticoagulant Treatment in Patients With Splanchnic Vein Thrombosis and History of Portal Hypertension–Related Bleeding

Liver International, Volume 45, Issue 6, June 2025.
ABSTRACT Splanchnic vein thrombosis (SVT) can be associated with liver cirrhosis or prothrombotic conditions, including myeloproliferative disorders, intra‐abdominal inflammation, solid cancers or surgery. While anticoagulation therapy improves outcomes in noncirrhotic patients and reduces all‐cause mortality in cirrhotic populations, its safety in ...
Rosa Talerico, Simona Pellegrino, Aurélie Plessier, Francesca Romana Ponziani, Angelo Porfidia, Francesco Landi, Antonio Gasbarrini, Roberto Pola, Francesco Santopaolo   +8 more
wiley   +1 more source

Soluble Urokinase Plasminogen Activator Receptor Predicts Survival and Hepatic Decompensation in Advanced Hepatocellular Carcinoma

Liver International, Volume 45, Issue 6, June 2025.
ABSTRACT Background and Aims The introduction of immune checkpoint inhibitor (ICI) based therapies has significantly improved the prognosis of patients with unresectable hepatocellular carcinoma (HCC). However, the variable treatment response and the uncertain benefit in patients with advanced liver cirrhosis emphasise the urgent need for prognostic ...
Fabian Artusa, Sven Lamatsch, Minh Duc Phan, Burcin Özdirik, Hilmar Berger, Mara Egerer, Jana Knorr‐Klocke, Janett Fischer, Rhea Veelken, Florian van Bömmel, Thomas Berg, Kai Kappert, Rudolf Tauber, Tobias Puengel, Cornelius Engelmann, Münevver Demir, Frank Tacke, Raphael Mohr   +17 more
wiley   +1 more source

Orbital varices

BMJ Case Reports, 2019
Michael Stuart, Howells, Rohit, Sharma
openaire   +3 more sources

Noninvasive Evaluation of Prolonged‐Release Pirfenidone in Compensated Liver Cirrhosis. ODISEA Study, a Randomised Trial

Liver International, Volume 45, Issue 6, June 2025.
ABSTRACT Background Advanced liver fibrosis (ALF) predicts an adverse prognosis in chronic liver disease. In addition to etiological treatment, a new approach to stop or reverse residual fibrosis is desirable. Objective To assess the efficacy and safety of prolonged‐release pirfenidone (PR‐PFD) versus placebo in compensated cirrhosis.
Linda E. Muñoz‐Espinosa, Aldo Torre, Laura Cisneros, Iaarah Montalvo, René Malé, Scherezada Mejía, Juan Ramón Aguilar, Javier Lizardi, Jaime Zuñiga‐Noriega, María Eugenia Icaza, Frida Gasca‐Díaz, Larissa Hernández‐Hernández, Paula Cordero‐Pérez, Luis Chi, Lilian Torres, Fátima Rodríguez‐Alvarez, Graciela Tapia, Jorge Luis Poo   +17 more
wiley   +1 more source

Poor Abilities of Noninvasive Biomarkers to Assess Esophagogastric Varices and Portal Hypertensive Gastropathy. [PDF]

Biomark Insights
Abassa KK, Guo X, Tan S, Liang Z, Tan S.
europepmc   +1 more source

Confirmation of endoscopic injection sclerotherapy by mucosal whitening in the treatment of hemorrhage of refractory recurrent tiny esophageal varices. [PDF]

Endoscopy
Nagashima K, Yamaguchi S, Maki R, Urushibara F, Suzuki T, Murohisa T, Irisawa A.   +6 more
europepmc   +1 more source

Can "Attenuation Subtraction", a Computed Tomography Scan-Based Factor, be Used as a Predictor of High-Risk Esophageal Varices in Cirrhotic Patients? A Retrospective Cohort Study. [PDF]

Health Sci Rep
Mansouri Tehrani MM, Bahari N, Goudarzi K, Salahshour F, Shekarchi B, Mansouri-Tehrani MM, Nouri M.   +6 more
europepmc   +1 more source

Role of liver transient elastography in detecting cirrhosis with esophageal and gastric varices and evaluating variceal severity. [PDF]

BMC Gastroenterol
Wang C.
europepmc   +1 more source

Endoscopic injection sclerotherapy with ligation for esophageal varices using single-use endoscope: Report of a video case. [PDF]

Endoscopy
Nagashima K, Inaba Y, Kashima K, Kunogi Y, Sakuma F, Yamamiya A, Irisawa A.   +6 more
europepmc   +1 more source

Variceal Haemorrhage

Journal of the Royal College of Physicians of London, 1973
openaire   +2 more sources